Two Biogen board members depart as company struggles to get Aduhelm off the groundnews2022-01-31T15:30:14+00:00January 31st, 2022|Fierce Pharma|
2 Biogen board members depart as company struggles to get Aduhelm off the groundnews2022-01-31T15:30:14+00:00January 31st, 2022|Fierce Pharma|
Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eyleanews2022-01-31T14:52:01+00:00January 31st, 2022|Fierce Pharma|
FDA issues 3 observations to Granules India site in US after pre-approval inspectionnews2022-01-31T14:42:10+00:00January 31st, 2022|Fierce Pharma|
FDA issues 3 observations to Granules India site in US after preapproval inspectionnews2022-01-31T14:42:10+00:00January 31st, 2022|Fierce Pharma|
Aurobindo subsidiary recalls one lot of injectable antibiotic after complaint of hair in vialnews2022-01-31T14:02:58+00:00January 31st, 2022|Fierce Pharma|
AstraZeneca reveals insurance fraud probe in China as officials say they’ve made criminal arrestsnews2022-01-31T13:56:04+00:00January 31st, 2022|Fierce Pharma|
Skip your pants? Merck ramps up its ‘Don’t Skip’ TV vaccination campaign with Wade and Unionnews2022-01-31T11:32:23+00:00January 31st, 2022|Fierce Pharma|
‘Digital sleuthing’ helps pharma connect with the right social media influencersnews2022-01-29T01:05:55+00:00January 29th, 2022|Fierce Pharma|
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDAnews2022-01-28T15:33:18+00:00January 28th, 2022|Fierce Pharma|
